Puma Biotechnology Inc (NASDAQ: PBYI) Stock Information | RedChip

Puma Biotechnology Inc (NASDAQ: PBYI) Listen to this Section


$2.70
+0.0500 ( +1.89% ) 380.0K

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Market Data


Open


$2.70

Previous close


$2.65

Volume


380.0K

Market cap


$132.18M

Day range


$2.65 - $2.78

52 week range


$2.13 - $7.73

Insider Ownership Transactions

Total Amount Purchased: -117,249.00 | $ -316,572.30

Date Type Amount Purchased Purchaser
2024-08-13 Sale -23358.00 MILLER MICHAEL PATRICK
2024-07-18 Sale -2598.00 Ludwig Jeffrey Jerome
2024-07-18 Sale -4156.00 NOUGUES MAXIMO F
2024-07-18 Sale -21920.00 AUERBACH ALAN H
2024-07-18 Sale -3637.00 HUNT DOUGLAS M
2024-07-02 Sale -6051.00 Ludwig Jeffrey Jerome
2024-07-02 Sale -5295.00 NOUGUES MAXIMO F
2024-07-02 Sale -18885.00 AUERBACH ALAN H
2024-07-02 Sale -4349.00 HUNT DOUGLAS M
2024-06-21 Sale -27000.00 Dorval Allison

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Aug 15, 2024
4 Insider transactions 1 Aug 13, 2024
8-k 8K-related 14 Aug 07, 2024
10-q Quarterly Reports 82 Aug 01, 2024
8-k 8K-related 16 Aug 01, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 18, 2024
4 Insider transactions 1 Jul 02, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.